Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial
Published Online: 2025-02-?
Journal: The Lancet Haematology•Publisher: Elsevier BV
Authors: Anja Klostergaard•Anna Lysén•Einar Haukås•Emil Hermansen•Fredrik Schjesvold•Frida Bugge Askeland•Lene Kongsgaard Nielsen•Liv Osnes•Pegah Abdollahi•Tatjana Alexandersen•Tobias S Slørdahl
